Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03562728 · ClinicalTrials.gov registry record · NA

Progressive Rehabilitation Therapy in Patients With Advanced Lung Disease

A NA study of Lung Transplant and Extracorporeal Membrane Oxygenation, sponsored by University of Maryland, Baltimore.

Active
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT03562728 is a NA study of Lung Transplant and Extracorporeal Membrane Oxygenation that is active but no longer recruiting, run by University of Maryland, Baltimore. The registered enrollment target is 70 participants, below the 1,271-participant average among 15 other Lung Transplant trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03562728, a NA study of Lung Transplant and Extracorporeal Membrane Oxygenation, is active but no longer recruiting, sponsored by University of Maryland, Baltimore.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The International Society of Heart and Lung Transplantation Registry data shows that there is a growing population of critically ill patients with advanced lung disease undergoing lung transplantation. The goal of our study is to evaluate the role of intensive physical therapy for patients with advanced lung disease requiring transplant or ECMO(extracorporeal membrane oxygenation)- bridge to transplant with emphasis on the restoration of functional independence and prevention of functional declines after lung transplantation. The project is a designed as a randomized prospective research study investigating the impact of a multi-modal rehabilitation program(MRP), which incorporates neuromuscular electric stimulation(NMES), strength and mobility training, and nutritional supplementation(NS) in ameliorating the loss of muscle mass and strength, and lower extremity balance, strength and coordination that will decrease time on the ventilator or ECMO, stay in the ICU and hospital.

Interventions

  • OTHER Standard of Care
  • DEVICE MRP and NMES(neuromuscular electric stimulation)

Study Locations (1)

Maryland

  • University of Maryland - Baltimore

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2019-01-13
Est. Completion 2027-11-01
Phase NA

Sponsor

University of Maryland, Baltimore

560 total trials

What the Registry Record Tells You About NCT03562728

The ClinicalTrials.gov registry entry for NCT03562728 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,271-participant average among 15 other Lung Transplant trials with a reported enrollment target (94% lower). The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Lung Transplant appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.

NCT03562728 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT03562728 about?

NCT03562728 is a clinical study titled "Progressive Rehabilitation Therapy in Patients With Advanced Lung Disease". The International Society of Heart and Lung Transplantation Registry data shows that there is a growing population of critically ill patients with advanced lung disease undergoing lung transplantation. The goal of our study is to evaluate the role of intensive physical therapy for patients with adv...

What is the current status of trial NCT03562728?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2019-01-13. Estimated completion is 2027-11-01.

What conditions does trial NCT03562728 study?

This clinical trial studies the following conditions: Lung Transplant, Extracorporeal Membrane Oxygenation, Advanced Lung Disease.

What interventions are being tested in trial NCT03562728?

The interventions under investigation include: Standard of Care (OTHER), MRP and NMES(neuromuscular electric stimulation) (DEVICE).

Who is sponsoring clinical trial NCT03562728?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03562728 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Transplant

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.